COSA 2015* Peey-Sei Kok
NHMRC Clinical Trials Centre, NSW, Australia
- This delegate is contactable by email.
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Timing and patterns of referral to palliative care for patients with metastatic non-small cell lung cancer (NSCLC) in South Western Sydney Local Health District (SWSLHD). (#151)
3:15 PM
Peey-Sei Kok
Best of the Best Posters - Clinical & Health services research
Baseline predictors of early treatment failure in patients with Platinum Resistant/ Refractory (PRR) and Potentially Platinum Sensitive (PPS) recurrent ovarian cancer (ROC) receiving ≥3 lines of chemotherapy- The Gynaecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS) (#203)
3:00 PM
Peey-Sei Kok
Posters1
Is it time to change the primary endpoint in clinical trials in recurrent ovarian cancer (ROC)? Symptom burden and outcomes in patients with platinum resistant/refractory (PRR) and potentially platinum sensitive ROC receiving ≥3 lines of chemotherapy (PPS) – The Gynecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS). (#167)
3:20 PM
Peey-Sei Kok
Best of the Best Posters - Survivorship & Supportive care